Found: 31
Select item for more details and to access through your institution.
Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate‐to‐severe atopic dermatitis treated with dupilumab.
- Published in:
- Pediatric Dermatology, 2024, v. 41, n. 1, p. 5, doi. 10.1111/pde.15418
- By:
- Publication type:
- Article
Predictors of family impact of juvenile localized scleroderma.
- Published in:
- Pediatric Dermatology, 2021, v. 38, n. 5, p. 1137, doi. 10.1111/pde.14683
- By:
- Publication type:
- Article
Novel use of Autoinflammatory Diseases Activity Index (AIDAI) captures skin and extracutaneous features to help manage pediatric DITRA: A case report and a proposal for a modified disease activity index in autoinflammatory keratinization disorders.
- Published in:
- Pediatric Dermatology, 2020, v. 37, n. 4, p. 670, doi. 10.1111/pde.14155
- By:
- Publication type:
- Article
Pediatric leukemia cutis: A case series.
- Published in:
- Pediatric Dermatology, 2019, v. 36, n. 5, p. 658, doi. 10.1111/pde.13864
- By:
- Publication type:
- Article
Cerebellar Atrophy in Craniofacial Morphea: A Report of 2 Cases with 1-year Neuroimaging Followup.
- Published in:
- 2020
- By:
- Publication type:
- case study
Patch Testing on Dupilumab: Reliable or Not?
- Published in:
- Cutis, 2022, v. 109, n. 3, p. 158, doi. 10.12788/cutis.0471
- By:
- Publication type:
- Article
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 5, p. 526, doi. 10.1001/jamadermatol.2023.0391
- By:
- Publication type:
- Article
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 6, p. 627, doi. 10.1001/jamadermatol.2014.5641
- By:
- Publication type:
- Article
Management of moderate‐to‐severe plaque psoriasis with biologics: A treat‐to‐target position paper.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15777
- By:
- Publication type:
- Article
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03122-w
- By:
- Publication type:
- Article
The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 8, p. 1490, doi. 10.1111/jdv.18926
- By:
- Publication type:
- Article
696 - Sustained improvements over 140 weeks in signs, symptoms, and quality of life with upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis: integrated results from the phase 3 Measure Up 1 and Measure Up 2 studies.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.070
- By:
- Publication type:
- Article
644 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an interim analysis of week 20-32 data from a real-world multicenter retrospective review.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.024
- By:
- Publication type:
- Article
643 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of short-term (week 8-20) data from a real-world multicenter retrospective review.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.023
- By:
- Publication type:
- Article
647 - Upadacitinib dose alterations in adolescent and adult patients with atopic dermatitis: a real-world multicenter retrospective review.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.026
- By:
- Publication type:
- Article
645 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of long-term (week 52) data from a real-world multicenter retrospective review.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.025
- By:
- Publication type:
- Article
641 - Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.022
- By:
- Publication type:
- Article
638 - Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.019
- By:
- Publication type:
- Article
639 - Efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients 2 to 5 years of age with mild to moderate atopic dermatitis (INTEGUMENT-PED): a phase 3 randomized controlled trial.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.020
- By:
- Publication type:
- Article
Rapid skin clearance and itch improvement with upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: results from a phase 3b head-to-head clinical trial (Heads Up).
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii30, doi. 10.1093/bjd/ljad498.033
- By:
- Publication type:
- Article
425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.045
- By:
- Publication type:
- Article
409 Efficacy and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: subgroup analysis of the Measure Up 1, Measure Up 2 and AD Up phase 3 clinical trials at 52 weeks.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.030
- By:
- Publication type:
- Article
Dermacase. Pretibial myxedema.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2653, doi. 10.1007/s13555-024-01243-8
- By:
- Publication type:
- Article
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque Psoriasis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 7, p. 1917, doi. 10.1007/s13555-024-01204-1
- By:
- Publication type:
- Article
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1127, doi. 10.1007/s13555-024-01157-5
- By:
- Publication type:
- Article
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 867, doi. 10.1007/s13555-023-00905-3
- By:
- Publication type:
- Article
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 2, p. 535, doi. 10.1007/s13555-022-00870-3
- By:
- Publication type:
- Article
Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 2, p. 381, doi. 10.1007/s13555-021-00661-2
- By:
- Publication type:
- Article